journal£ºEuropean Journal of Cancer
Title: Discovery of INCB123667, a potent and selective cyclin-dependent kinase 2 (CDK2) inhibitor for the treatment of cyclin E dysregulated cancers
Authors£ºS. Wee, M. Ye, Y. Lo, M. Hansbury, N. Shin, M. Weber, V. Roman, L. Huo, H. Skaggs, K. Drake, K. Kapilashrami, K. Stump, J. Yang, S. Chand, C. Timmers, J. Hummel, Y. Ye, G. Zhang, Y.O. Yang, M. Covington, L. Wu, H. Koblish, S. Kim
Published date£º2022-10-27
DOI: 10.1016/S0959-8049(22)01010-3
Article link: https://doi.org/10.1016/S0959-8049(22)01010-3
Article Source£ºElsevier BV¡£
|